Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.4926.404.985.735.29

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 9.49 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20259.49
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2025 9.49
-64.05
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹72.3 Cr 14.4% 2% -41% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

14.4%

2%

-41%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses